Ali, RıdvanÖzçelik, Tülay2024-09-202024-09-202006-01-011573-398Xhttps://doi.org/10.2174/157339806775486191https://www.eurekaselect.com/article/417https://hdl.handle.net/11452/44979Invasive pulmonary aspergillosis (IPA) is a frequently life-threatening fungal infection that complicates acute leukemia patients following conventional chemotherapy and bone marrow transplantation. The mortality rate reaches 50% in leukemic patients during chemotherapy-induced neutropenia and can exceed 90% in bone marrow transplantation patients. Despite advances in antimicrobial therapy and supportive care, IPA remains a major clinical problem in patients with acute leukemia. Current issues for IPA in adults are reviewed.eninfo:eu-repo/semantics/closedAccessStem-cell transplantationLinked-immunosorbent-assayPolymerase-chain-reactionLiposomal amphotericin-bAcute myeloid-leukemiaBronchoalveolar lavage samplesEmpirical antifungal therapyWorking-party agihoFungal-infectionsBone-marrowInvasive pulmonary aspergillosis (ipa)Acute leukemiaScience & technologyLife sciences & biomedicineRespiratory systemArticle0002126168000023132110.2174/1573398067754861911875-6387